Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS9 | O00182 | 4/20 | 0.46 |
| ▸ | LGALS1 | P09382 | 4/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 4/20 | 0.46 |
| ▸ | LGALS7; LGALS7B | P47929 | 3/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | TACR2 | P21452 | 3/20 | 0.39 |
| ▸ | SELP | P16109 | 6/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.39 |
| ▸ | SELE | P16581 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11981213 | 1.00 | LGALS9 (0.46) | LGALS9LGALS1LGALS3LGALS7; LGALS7BNT5E | |
| SCHEMBL13707194 | 1.00 | LGALS9 (0.46) | LGALS9LGALS1LGALS3LGALS7; LGALS7BNT5E | |
| SCHEMBL10148626 | 0.91 | LGALS3 (0.58) | LGALS9LGALS1LGALS3LGALS7; LGALS7BNT5E | |
| SCHEMBL13855490 | 0.91 | LGALS3 (0.58) | LGALS9LGALS1LGALS3LGALS7; LGALS7BNT5E | |
| SCHEMBL10148629 | 0.90 | NT5E (0.43) | LGALS9LGALS1LGALS3LGALS7; LGALS7BNT5E | |
| SCHEMBL13707193 | 0.87 | LGALS9 (0.43) | LGALS9LGALS1LGALS3LGALS7; LGALS7BNT5E | |
| SCHEMBL19891729 | 0.82 | NT5E (0.59) | NT5ETACR2PTPN1 | |
| SCHEMBL19891576 | 0.82 | NT5E (0.59) | NT5ETACR2PTPN1 | |
| SCHEMBL19891528 | 0.82 | NT5E (0.59) | NT5ETACR2PTPN1 | |
| SCHEMBL13855489 | 0.81 | NT5E (0.44) | LGALS9LGALS1LGALS3LGALS7; LGALS7BNT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9243018-B2 | Synthetic heparin pentasaccharides | DR. REDDY'S LABORATORIES, SA (CH) | 2016-01-26 | — | — | US | disclosed |
| US-20150005485-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | ALCHEMIA LIMITED (AU) | 2015-01-01 | — | — | US | disclosed |
| US-8404833-B2 | Synthetic heparin disaccharides | ALCHEMIA LIMITED (AU) | 2013-03-26 | — | — | US | disclosed |
| US-20120220759-A1 | SYNTHETIC HEPARIN DISACCHARIDES | ALCHEMIA LIMITED (AU) | 2012-08-30 | — | — | US | disclosed |
| US-20120208993-A1 | SYNTHETIC HEPARIN TRISACCHARIDES | ALCHEMIA LIMITED (AU) | 2012-08-16 | — | — | US | disclosed |
| US-8114970-B2 | Synthetic heparin monosaccharides | ALCHEMIA LIMITED (AU) | 2012-02-14 | — | — | US | disclosed |
| US-20090187013-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | ALCHEMIA LIMITED (AU) | 2009-07-23 | — | — | US | disclosed |
| US-7541445-B2 | Synthetic heparin pentasaccharides | ALCHEMIA LIMITED (AU) | 2009-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090187013-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | HPSE, DDOST, STT3A | LGALS9 514/4885LGALS1 586/4885LGALS3 454/4885 |
| US-20120220759-A1 | SYNTHETIC HEPARIN DISACCHARIDES | HPSE, DDOST, STT3A | LGALS9 550/4885LGALS1 621/4885LGALS3 447/4885 |
| US-20150005485-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | HPSE, DDOST, STT3A | LGALS9 639/4885LGALS1 645/4885LGALS3 574/4885 |
| US-20120208993-A1 | SYNTHETIC HEPARIN TRISACCHARIDES | HPSE, SERPINC1, DDOST | LGALS9 1146/4885LGALS1 998/4885LGALS3 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.